These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 16030294)

  • 21. Genetic polymorphisms and head and neck cancer risk (Review).
    Hiyama T; Yoshihara M; Tanaka S; Chayama K
    Int J Oncol; 2008 May; 32(5):945-73. PubMed ID: 18425322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tissue microarray - a high-throughput molecular analysis in head and neck cancer.
    Radhakrishnan R; Solomon M; Satyamoorthy K; Martin LE; Lingen MW
    J Oral Pathol Med; 2008 Mar; 37(3):166-76. PubMed ID: 18251941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Breast cancer patients with p53 Pro72 homozygous genotype have a poorer survival.
    Tommiska J; Eerola H; Heinonen M; Salonen L; Kaare M; Tallila J; Ristimäki A; von Smitten K; Aittomäki K; Heikkilä P; Blomqvist C; Nevanlinna H
    Clin Cancer Res; 2005 Jul; 11(14):5098-103. PubMed ID: 16033823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of EGFR, p53 and E-cadherin in mucoepidermoid cancer of the salivary glands: a retrospective case series.
    Hoyek-Gebeily J; Nehmé E; Aftimos G; Sader-Ghorra C; Sargi Z; Haddad A
    J Med Liban; 2007; 55(2):83-8. PubMed ID: 17685120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Re: Reporting recommendations for tumor marker prognostic studies (REMARK).
    Popat S; Houlston RS
    J Natl Cancer Inst; 2005 Dec; 97(24):1855; author reply 1855-6. PubMed ID: 16368950
    [No Abstract]   [Full Text] [Related]  

  • 26. Prognostic analysis of rectal stromal tumors by reference of National Institutes of Health risk categories and immunohistochemical studies.
    Tsai MC; Lin JW; Lin SE; Chen HH; Lee CM; Hu TH
    Dis Colon Rectum; 2008 Oct; 51(10):1535-43. PubMed ID: 18633679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of head-and-neck cancer biomarkers previously discovered and identified using iTRAQ-labeling and multidimensional liquid chromatography-tandem mass spectrometry.
    Matta A; DeSouza LV; Shukla NK; Gupta SD; Ralhan R; Siu KW
    J Proteome Res; 2008 May; 7(5):2078-87. PubMed ID: 18407684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epstein-Barr viral infection in extranodal lymphoma of the head and neck: correlation with prognosis and response to treatment.
    Bahnassy AA; Zekri AR; Asaad N; El-Houssini S; Khalid HM; Sedky LM; Mokhtar NM
    Histopathology; 2006 Apr; 48(5):516-28. PubMed ID: 16623777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relation between hypoxia-inducible factor (HIF)-1alpha expression with p53 expression and outcome in surgically treated supraglottic laryngeal cancer.
    Cabanillas R; Rodrigo JP; Secades P; Astudillo A; Nieto CS; Chiara MD
    J Surg Oncol; 2009 May; 99(6):373-8. PubMed ID: 19226532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative analysis of prognostic significance of molecular markers of apoptosis with clinical stage and tumor differentiation in patients with colorectal cancer: a single institute experience.
    Ivanov K; Kolev N; Tonev A; Nikolova G; Krasnaliev I; Softova E; Tonchev A
    Hepatogastroenterology; 2009; 56(89):94-8. PubMed ID: 19453036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The incidence and impact of comorbidity diagnosed after the onset of head and neck cancer.
    Yung KC; Piccirillo JF
    Arch Otolaryngol Head Neck Surg; 2008 Oct; 134(10):1045-9. PubMed ID: 18936348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tissue microarray analysis of the prognostic value of E-cadherin, Ki67, p53, p27, survivin and MSH2 expression in upper urinary tract transitional cell carcinoma.
    Fromont G; Rouprêt M; Amira N; Sibony M; Vallancien G; Validire P; Cussenot O
    Eur Urol; 2005 Nov; 48(5):764-70. PubMed ID: 16126329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of Ki-67 and p53 as tumor markers in salivary gland malignancies in Finland: an evaluation of 212 cases.
    Luukkaa H; Klemi P; Leivo I; Vahlberg T; Grénman R
    Acta Oncol; 2006; 45(6):669-75. PubMed ID: 16938809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic impact of p53 protein overexpression in patients with node-negative lung adenocarcinoma.
    Suzuki H; Kawaguchi T; Hasegawa T; Yonechi A; Ohsugi J; Higuchi M; Yamada F; Shio Y; Fujiu K; Kanno R; Ohishi A; Gotoh M
    Cancer Lett; 2006 Jun; 237(2):242-7. PubMed ID: 16102896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinicopathological and immunohistochemical markers after radical gastrectomy for gastric cancer.
    Potrc S; Gadiijev E; Hajdinjak T; Kavalar R
    Hepatogastroenterology; 2007; 54(73):308-14. PubMed ID: 17419281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HER2 expression predicts improved survival in patients with cervical node-positive head and neck squamous cell carcinoma.
    Tse GM; Yu KH; Chan AW; King AD; Chen GG; Wong KT; Tsang RK; Chan AB
    Otolaryngol Head Neck Surg; 2009 Oct; 141(4):467-73. PubMed ID: 19786214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of p53 and X-ray repair cross-complementing group 1 polymorphisms on prostate-specific antigen recurrence in prostate cancer post radical prostatectomy.
    Huang SP; Huang CY; Wang JS; Liu CC; Pu YS; Yu HJ; Yu CC; Wu TT; Huang CH; Wu WJ; Chou YH; Wu MT
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6632-8. PubMed ID: 18006764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of molecular markers and gene profiling in head and neck cancers.
    Gold KA; Kim ES
    Curr Opin Oncol; 2009 May; 21(3):206-11. PubMed ID: 19346943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Ki-67 and p53 expression as prognosticators of clinical course aggressiveness of squamous cell cancer of the larynx].
    Gorban' NA; Ten VP; Pankratov VA
    Vopr Onkol; 2007; 53(6):668-73. PubMed ID: 18416135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.